FDA 510(k) Product Evidence Map — similar-device, predicate landscape, and market-entry research
Start with the device. Then map the public FDA evidence around it. The FDA view of the Medical Device Product Evidence Map organizes candidate FDA product-code clues, 510(k) records, similar-device and candidate predicate landscape, indications and technology comparisons, recognized standards, FDA Recalls, MAUDE adverse events, Warning Letters, and Safety Communications around your product family. The output is source-backed evidence and candidate review points for qualified RA/QA or consultant review — never a regulatory determination.
For founders, manufacturers, RA/QA teams, and regulatory consultants. For RA/QA or consultant review.
This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine FDA classification, submission pathway, predicate status, substantial equivalence, compliance, safety, or effectiveness. We organize public FDA sources so qualified RA/QA professionals or regulatory consultants can review and decide.
What should I check before a 510(k) consultant meeting?
Before a paid 510(k) consultant call, organize a candidate FDA product-code shortlist, a candidate predicate shortlist with K-numbers and decision dates, a similar-product comparison covering indications and technological characteristics, a public safety-history scan covering the candidate similar-device set, a candidate recognized-standards reference, and your own written open questions. The FDA view of the Product Evidence Map below organizes these into a single product-centered interface.
How do I research similar FDA devices?
Surface a candidate product code via FDA Product Classification. Query the FDA 510(k) database by that code, applicant, device name, or decision date. Read the 510(k) Summaries and Decision Summaries to compile a candidate predicate shortlist with source-cited indications and technological-characteristics notes. Use openFDA for bulk programmatic retrieval when the shortlist exceeds the web interface. The candidate predicate shortlist and similar-product comparison are research outputs — never a final predicate selection or substantial equivalence determination.
For the step-by-step database workflow, see the open-access FDA 510(k) similar-device research workflow.
What public FDA evidence should be organized before market entry?
Twelve public-source evidence areas carry the most signal: candidate product-code / classification clues, 510(k) records, similar-device / candidate predicate landscape, indications comparison, technology characteristics comparison, FDA guidance / special-controls clues, recognized-standards reference, FDA Recalls, MAUDE adverse events, FDA Warning Letters, FDA Safety Communications, and consultant-prep questions. Each is rendered as an interactive evidence area in the FDA view of the Product Evidence Map below — click any area to read its meaning, why it may matter, the public sources commonly reviewed, what TrueMedDevice can prepare as candidate review points, and the relevant boundary language.
U.S. / FDA view
Map public FDA evidence around your medical device product family.
Start with the device. Then map the candidate product-code, similar-device landscape, safety-history, recognized-standards, and consultant-prep evidence around it.
This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine FDA classification, submission pathway, predicate status, substantial equivalence, compliance, safety, or effectiveness. We organize public-source evidence and prepare candidate review points so qualified RA/QA professionals or regulatory consultants can review and decide.
Center · Your product family
Your Product Family
Start with the device. Then map the public evidence around it.
Ring 0 — Product facts
Inputs about the device- Intended useOne-sentence statement of what the device is for.
- Indications / claimsPopulation, condition, or context the device is indicated for.
- Technology characteristicsPrinciple of operation, energy used, key materials, sensors, algorithms.
- Target usersClinician, technician, patient, lay caregiver — and where applicable, training requirements.
- Use environmentHospital, clinic, home, ambulance, mobile, sterile field, etc.
- Software / connectivityOn-device software, cloud connectivity, cybersecurity scope, interoperability.
- Accessories / componentsDisposables, sensors, leads, sterilization-sensitive parts, packaging.
- Target marketU.S. / FDA, Canada / Health Canada, or both. Phasing if both.
- Comparable productsWorking list of similar marketed devices already known to the team.
The center captures the device. The evidence areas below capture the public-source evidence TrueMedDevice can organize around it.
Ring 1 — Evidence areas
U.S. / FDA evidence areas
Click any evidence area to expand its meaning, why it may matter, which public sources are commonly reviewed, and what TrueMedDevice can prepare as candidate review points for qualified RA/QA review.
Review output — Next step
Hand the evidence to qualified RA/QA or consultant review
TrueMedDevice provides public-source research and evidence organization support. This page and any related Evidence Pack do not determine device classification, predicate suitability, regulatory pathway, licence route, clearance likelihood, compliance status, reportability, or legal/regulatory obligations. Final decisions remain with the company's qualified RA/QA, regulatory, legal, or consultant professionals.
Boundary: This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine FDA classification, submission pathway, predicate status, substantial equivalence, compliance, safety, or effectiveness. We organize public-source evidence and prepare candidate review points so qualified RA/QA professionals or regulatory consultants can review and decide.
What the FDA view of the Product Evidence Map surfaces
For U.S. / FDA market-entry research, the map surfaces a consistent set of public-source evidence areas around a candidate device family — never a regulatory determination:
- Product code / classification clues — candidate three-letter FDA product codes with 21 CFR citations and device-class indications.
- 510(k) records — clearance entries from the FDA 510(k) database, including 510(k) Summaries and Decision Summaries for the candidate product code.
- Similar devices and candidate predicate landscape — direct and indirect similar devices surfaced as research inputs for a manufacturer's RA/QA-led candidate predicate shortlist.
- Indications and technological characteristics comparison — side-by-side cleared indications and technology notes for the candidate similar-device set.
- Public FDA safety history — FDA Recalls, MAUDE adverse-event narratives, Warning Letters, Safety Communications, and Import Alerts for the product family.
- Guidance, special controls, and recognized standards — candidate FDA guidance documents, 21 CFR special controls, and recognized consensus standards for the candidate product code.
- Consultant-prep questions — an open-questions packet built from the evidence-area scan for the first paid consultant call.
Each evidence area renders as an interactive card above. Every output is a candidate review point for qualified RA/QA or consultant review — sourced and dated.
What the FDA Product Evidence Map does not determine
The map organizes public-source FDA evidence. It does not determine:
- FDA classification — final device class is FDA's call when a submission is reviewed.
- Submission pathway — 510(k), De Novo, PMA, or otherwise is a manufacturer-and-RA/QA determination prepared with consultant input, not a Product Evidence Map output.
- Predicate suitability or substantial equivalence — substantial equivalence is FDA's determination against a manufacturer-selected predicate. The candidate predicate shortlist surfaced here is research, never a final selection.
- Clearance likelihood, compliance status, reportability — none of these are inferred, predicted, or scored by the map.
- Safety or effectiveness — neither for the candidate device nor for any device in the similar-device landscape.
Final decisions remain with the company's qualified RA/QA, regulatory, legal, or consultant professionals in consultation with FDA.
Why product-centered evidence mapping helps before a consultant conversation
Regulatory research that starts with a checklist tends to drift — the reader scans the rule and then tries to match the device into it. Research that starts with the device, then maps the public evidence around it, keeps the candidate device at the center of every conversation. Candidate FDA product-code clues lead to candidate predicates; candidate predicates frame the indications and technology comparison; the public FDA safety-history scan focuses on what has actually been observed in this product family.
By the time the first paid FDA consultant call begins, the qualified RA/QA team or consultant is reviewing source-cited candidate review points — not assembling them. The consultant spends the hour on judgment, not on retrieval.
Related U.S. / FDA research
- U.S. Market-Entry Research Guide — what to prepare before consulting an RA/QA specialist
- FDA 510(k) Similar-Device Research Workflow — step-by-step source walk-through
- Medical Device Safety-History Scan Before Market Entry — public-source review-point playbook
- Prepare for Your First Regulatory Consultant Meeting — eight-block checklist
- U.S. / FDA Market-Entry Product Evidence Pack — the service that ships the artifacts above
- Request a Product ID intake — start the FDA research on your device
Frequently asked questions
What should I check before a 510(k) consultant meeting?
Before a 510(k) consultant meeting, gather a written intended-use statement, candidate FDA product-code clues with sources, candidate similar-device shortlist (K-numbers), a similar-product comparison covering indications and technological characteristics, a public safety-history scan (FDA MAUDE, Recalls, Warning Letters, Safety Communications) for the candidate device set, a candidate recognized-standards reference, and your own list of open questions. The FDA view of the Product Evidence Map organizes these public-source evidence areas around your product family. Final classification, predicate selection, pathway, and substantial-equivalence decisions remain with qualified RA/QA professionals or regulatory consultants in consultation with FDA.
How do I research similar FDA devices?
Start with FDA Product Classification to surface candidate three-letter product codes for your device description. Query the FDA 510(k) database by candidate product code, applicant, device name, or decision date. Read the 510(k) Summaries and Decision Summaries to compare intended use and technological characteristics. The openFDA API at api.fda.gov also exposes structured access. Our open-access FDA 510(k) similar-device research workflow walks the four FDA public sources step-by-step.
What public FDA evidence should be organized before market entry?
Twelve public-source evidence areas commonly carry the most signal: candidate product-code / classification clues, 510(k) records, similar-device / candidate predicate landscape, indications comparison, technology characteristics comparison, FDA guidance / special-controls clues, recognized-standards reference, FDA Recalls, MAUDE adverse events, FDA Warning Letters, FDA Safety Communications, and consultant-prep questions. The FDA view of the Product Evidence Map organizes each of these around your product family as a candidate review point for qualified RA/QA or consultant review.
Does the Product Evidence Map determine my FDA classification or predicate?
No. The Product Evidence Map surfaces candidate FDA product-code clues and a candidate predicate / similar-device landscape, but it does not determine FDA classification, submission pathway, predicate status, or substantial equivalence. Those are FDA determinations that the manufacturer's RA/QA team and qualified consultant team prepare for and submit. The map's outputs are inputs for qualified RA/QA or consultant review.
How does this differ from filing a 510(k)?
Filing a 510(k) is the FDA submission action — performed by the manufacturer's RA/QA team with consultant input. The Product Evidence Map is research preparation: it organizes the candidate predicate shortlist, similar-product comparison, safety-history scan, recognized-standards reference, and consultant-prep questions that go into the 510(k) authoring process. The map is preparation; the submission is RA/QA's work.
Want this FDA research run on your product?
The U.S. / FDA Market-Entry Product Evidence Pack delivers the twelve evidence areas above — candidate product-code shortlist, candidate predicate landscape, similar-product comparison, safety-history scan, recognized-standards reference, source ledger, and consultant briefing sheet — as a source-cited artifact for qualified RA/QA or consultant review.
Request a FDA Product Family Evidence PackThis is not regulatory, legal, or compliance advice. TrueMedDevice does not determine FDA classification, submission pathway, predicate status, substantial equivalence, compliance, safety, or effectiveness. We prepare a source-backed evidence pack from public FDA sources so qualified RA/QA professionals or regulatory consultants can review and decide.
TrueMedDevice provides public-source research and evidence organization support. This page does not determine device classification, predicate suitability, regulatory pathway, clearance likelihood, compliance status, reportability, or legal/regulatory obligations. Final decisions remain with the company's qualified RA/QA, regulatory, legal, or consultant professionals. We prepare source-backed evidence and candidate review points; similar-product comparison against a candidate predicate is research, not a final substantial-equivalence determination.